Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ)
002693.SZ Stock Price Chart
Explore Hainan Shuangcheng Pharmaceuticals Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002693.SZ price movements and trends.
002693.SZ Company Profile
Discover essential business fundamentals and corporate details for Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
8 Aug 2012
Employees
474.00
Website
https://www.shuangchengmed.comCEO
Jianming Li
Description
Hainan Shuangcheng Pharmaceuticals Co., Ltd. researches, develops, manufactures, and markets synthesized peptide drugs and active pharmaceutical ingredients worldwide. It offers somatostatin, thymosin, clindamycin hydrochloride, thymopentin, L-carnitine, uranin hydrobromide, inosine, cyclophosphine adenosine, motidine, scopolamine, and sodium ferulate for injections, as well as vitamin B6. The company was founded in 2000 and is based in Haikou, the People's Republic of China.
002693.SZ Financial Timeline
Browse a chronological timeline of Hainan Shuangcheng Pharmaceuticals Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 30 Jun 2025
EPS came in at -¥0.02 , while revenue for the quarter reached ¥47.45M .
Earnings released on 22 May 2025
EPS came in at -¥0.10 , while revenue for the quarter reached ¥47.25M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.02 , while revenue for the quarter reached ¥36.68M .
Earnings released on 29 Sept 2024
EPS came in at -¥0.05 , while revenue for the quarter reached ¥30.66M .
Earnings released on 30 Jun 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥52.13M .
Earnings released on 22 May 2024
EPS came in at -¥0.11 , while revenue for the quarter reached ¥53.68M .
Earnings released on 31 Mar 2024
EPS came in at -¥0.02 , while revenue for the quarter reached ¥42.76M .
Earnings released on 30 Sept 2023
EPS came in at -¥0.03 , while revenue for the quarter reached ¥43.24M .
Earnings released on 30 Jun 2023
EPS came in at ¥0.01 , while revenue for the quarter reached ¥57.53M .
Earnings released on 31 Mar 2023
EPS came in at ¥0.00 , while revenue for the quarter reached ¥81.49M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.02 , while revenue for the quarter reached ¥76.89M .
Earnings released on 30 Sept 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥71.05M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.00 , while revenue for the quarter reached ¥53.58M .
Earnings released on 31 Mar 2022
EPS came in at ¥0.01 , while revenue for the quarter reached ¥73.23M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.04 , while revenue for the quarter reached ¥69.47M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.03 , while revenue for the quarter reached ¥77.16M .
Earnings released on 30 Jun 2021
EPS came in at ¥0.03 , while revenue for the quarter reached ¥89.90M .
Earnings released on 29 Apr 2021
EPS came in at -¥0.06 , while revenue for the quarter reached ¥79.51M .
Earnings released on 31 Mar 2021
EPS came in at -¥0.01 , while revenue for the quarter reached ¥83.76M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.02 , while revenue for the quarter reached ¥76.08M .
002693.SZ Stock Performance
Access detailed 002693.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.